ALTU-135 Terminated Phase 3 Trials for Exocrine Pancreatic Insufficiency Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00500084Phase III ALTU-135 CP Safety Trial